Immunic
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
IMUX Key Statistics
Stock Snapshot
As of today, Immunic(IMUX) shares are valued at $7.41. The company's market cap stands at 100.29M, with a P/E ratio of -1.54.
On 2026-10-24, Immunic(IMUX) stock moved within a range of $7.00 to $7.80. With shares now at $7.41, the stock is trading +5.9% above its intraday low and -5.0% below the session's peak.
Trading volume for Immunic(IMUX) stock has reached 366.91K, versus its average volume of 373.51K.
The stock's 52-week range extends from a low of $5.06 to a high of $17.43.
The stock's 52-week range extends from a low of $5.06 to a high of $17.43.
IMUX News
Cantor Fitzgerald analyst Yanni Souroutzidis initiated coverage of Immunic (IMUX) with an Overweight rating. Published first on TheFly – the ultimate source fo...
...
Immunic (IMUX) announced the appointment of Jaa Roberson as chief people officer, or CPO, effective immediately. Roberson will report directly to CEO Erik Lundg...
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.